LDL oxidation by platelets propagates platelet activation via an oxidative stress-mediated mechanism

Atherosclerosis

Volumn 237, Issue 1, 2014, Pages 108-116

  Carnevale, Roberto ^a   Bartimoccia, Simona ^a   Nocella, Cristina ^a   Di Santo, Serena ^a   Loffredo, Lorenzo ^a   Illuminati, Giulio ^a   Lombardi, Elisabetta ^b   Boz, Valentina ^b   Del Ben, Maria ^a   De Marco, Luigi ^b   Pignatelli, Pasquale ^a   Violi, Francesco ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

Author keywords

Atherosclerosis; NADPH oxidase; Ox LDL; Oxidative stress

Indexed keywords

8 ISOPROSTAGLANDIN F2 ALPHA; COLLAGEN TYPE 1; LOW DENSITY LIPOPROTEIN RECEPTOR; OXIDIZED LOW DENSITY LIPOPROTEIN; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; THROMBOXANE B2; 8-EPI-PROSTAGLANDIN F2ALPHA; COLLAGEN; CYBB PROTEIN, HUMAN; LOW DENSITY LIPOPROTEIN; MEMBRANE PROTEIN; PROSTAGLANDIN F2 ALPHA;

ADULT; ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME PHOSPHORYLATION; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HYPERCHOLESTEROLEMIA; IMMUNOBLOTTING; IN VITRO STUDY; MALE; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; ANALOGS AND DERIVATIVES; BLOOD; CASE CONTROL STUDY; CHEMISTRY; DEFICIENCY; GENETICS; METABOLISM; MIDDLE AGED; PATHOLOGY; PERFUSION; THROMBOCYTE; THROMBOSIS;

ADULT; ATHEROSCLEROSIS; BLOOD PLATELETS; CASE-CONTROL STUDIES; COLLAGEN; DINOPROST; FEMALE; HUMANS; HYPERCHOLESTEROLEMIA; LIPOPROTEINS, LDL; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; NADPH OXIDASE; OXIDATIVE STRESS; PERFUSION; PLATELET ACTIVATION; THROMBOSIS;

EID: 84907776794     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2014.08.041     Document Type: Article

References (24)

1. Pirillo A., Norata G.D., Catapano A.L. LOX-1, OxLDL, and atherosclerosis. Mediators Inflamm 2013, 2013:1-12.
2. Levitan I., Volkov S., Subbaiah P.V. Oxidized LDL: diversity, patterns of recognition, and pathophysiology. Antioxid Redox Signal 2010, 13:39-75.
3. Chen M., Kakutani M., Naruko T., Ueda M., Narumiya S., Masaki T., et al. Activation-dependent surface expression of LOX-1 in human platelets. Biochem Biophys Res Commun 2001, 282:153-158.
4. Chen K., Febbraio M., Li W., Silverstein R.L. Aspecific CD36-dependent signaling pathway is required for platelet activation by oxidized low-density lipoprotein. Circ Res 2008, 102:1512-1519.
5. Podrez E.A., Byzova T.V., Febbraio M., Salomon R.G., Ma Y., Valiyaveettil M., et al. Platelet CD36 links hyperlipidemia, oxidant stress and a prothrombotic phenotype. Nat Med 2007, 13:1086-1095.
6. Mahfouz M.M., Kummerow F.A. Oxidized low-density lipoprotein (LDL) enhances thromboxane A(2) synthesis by platelets, but lysolecithin as a product of LDL oxidation has an inhibitory effect. Prostaglandins Other Lipid Mediat 2000, 62:183-200.
7. Mehta J.L., Sanada N., Hu C.P., Chen J., Dandapat A., Sugawara F., et al. Deletion of LOX- 1 reduces atherogenesis in LDLR knockout mice fed high cholesterol diet. Circ Res 2007, 100:1634-1642.
8. Vasconcelos E.M., Degasperi G.R., de Oliveira H.C., Vercesi A.E., de Faria E.C., Castilho L.N. Reactive oxygen species generation in peripheral blood monocytes and oxidized LDL are increased in hyperlipidemic patients. Clin Biochem 2009, 42:1222-1227.
9. Carnevale R., Pignatelli P., Lenti L., Buchetti B., Sanguigni V., Di Santo S., et al. LDL are oxidatively modified by platelets via GP91(phox) and accumulate in human monocytes. FASEB J 2007, 21:927-934.
10. Pignatelli P., Sanguigni V., Lenti L., Ferro D., Finocchi A., Rossi P., et al. gp91phox-dependent expression of platelet CD40 ligand. Circulation 2004, 110:1326-1329.
11. Pignatelli P., Lenti L., Sanguigni V., Frati G., Simeoni I., Gazzaniga P.P., et al. Carnitine inhibits arachidonic acid turnover, platelet function, and oxidative stress. Am J Physiol Heart Circ Physiol 2003, 284:H41-H48.
12. Krötz F., Sohn H.Y., Gloe T., Zahler S., Riexinger T., Schiele T.M., et al. NAD(P)H oxidase-dependent platelet superoxide anion release increases platelet recruitment. Blood 2002, 100:917-924.
13. Pulcinelli F.M., Pignatelli P., Pesciotti M., Sebastiani S., Parisi S., Gazzaniga P.P. Mechanism of the persisting TxA2 receptor antagonism by picotamide. Thromb Res 1997, 85:207-215.
14. 2+] required for secretion of serotonin from permeabilized blood platelets. Evidence of a role for a GTP-binding protein in platelet. FEBS Lett 1984, 174:90-95.
15. Hoffman S.W., Roof R.L., Stein D.G. Areliable and sensitive enzyme immunoassay method for measuring 8-isoprostaglandin F2 alpha: a marker for lipid peroxidation after experimental brain injury. J Neurosci Methods 1996, 68:133-136.
16. Pignatelli P., Carnevale R., Cangemi R., Loffredo L., Sanguigni V., Stefanutti C., et al. Atorvastatin inhibits gp91phox circulating levels in patients with hypercholesterolemia. Arterioscler Thromb Vasc Biol 2010, 30:360-367.
17. Fortuño A., Bidegain J., Robador P.A., Hermida J., López-Sagaseta J., Beloqui O., et al. Losartan metabolite EXP3179 blocks NADPH oxidase-mediated superoxide production by inhibiting protein kinase C: potential clinical implications in hypertension. Hypertension 2009, 54:744-750.
18. Savage B., Almus-Jacobs F., Ruggeri Z.M. Specific synergy of multiple substrate-receptor interactions in platelet thrombus formation under flow. Cell 1998, 94:657-666.
19. Mazzucato M., Cozzi M.R., Battiston M., Jandrot-Perrus M., Mongiat M., Marchese P., et al. Distinct spatio-temporal Ca2+ signaling elicited by integrin alpha2beta1 and glycoprotein VI under flow. Blood 2009, 114:2793-2801.
20. Fujimoto S., Hartung D., Ohshima S., Edwards D.S., Zhou J., Yalamanchili P., et al. Molecular imaging of matrix metalloproteinase in atherosclerotic lesions: resolution with dietary modification and statin therapy. J Am Coll Cardiol 2008, 52:1847-1857.
21. Siegel-Axel D., Daub K., Seizer P., Lindemann S., Gawaz M. Platelet lipoprotein interplay: trigger of foam cell formation and driver of atherosclerosis. Cardiovasc Res 2008, 78:8-17.
22. Ferroni P., Basili S., Falco A., Davì G. Oxidant stress and platelet activation in hypercholesterolemia. Antioxid Redox Signal 2004, 6:747-756.
23. Duffy D., Holmes D.N., Roe M.T., Peterson E.D. The impact of high-density lipoprotein cholesterol levels on long-term outcomes after non-ST-elevation myocardial infarction. Am Heart J 2012, 163:705-713.
24. Pendyala S., Usatyuk P.V., Gorshkova I.A., Garcia J.G., Natarajan V. Regulation of NADPH oxidase in vascular endothelium: the role of phospholipases, protein kinases, and cytoskeletal proteins. Antioxid Redox Signal 2009, 11:841-860.